ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2014 on Thursday, February 26, 2015, after the U.S. financial markets close. ACADIA’s management will host a conference call and webcast on Thursday, February 26, 2015, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.
Help employers find you! Check out all the jobs and post your resume.
